Silver Book Fact

Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs therapies; looking for the cause of the disease and continuing to search for environmental and genetic factors; and working to develop new protective drugs that can delay, reverse, or even prevent the disease.

National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH. Parkinson’s Disease Information Page; 2007. http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm

Reference

Title
Parkinson’s Disease Information Page
Publication Date
2007
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 out-of-pocket costs for individuals and families dealing with the…  
  • A study of rasagiline mesylate in Parkinson’s disease patients showed improved motor fluctuations and other Parkinson’s disease symptoms.  
  • A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.  
  • Impact of Slowed Progression on Alzheimer’s Disease Growth, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
  • One study found that dopaminergenic therapies for Parkinson’s disease patients resulted in lower dyskinesias as well as lower incidences of freezing, drowsiness, and edema–resulting in better quality-of-life through symptom control.